Delivery Order SPE2DB20D7066-SPE2DB25FC3GH

Award Date 5/9/25
Potential Completion Date 5/12/25
Potential Value $7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a Delivery Order valued at $2,432.95 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tenofovir Disoproxil Fumarate 300 mg tablets, with an ultimate completion date of May 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
The U.S. Defense Logistics Agency (DLA) awarded a $1,236.12 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,564,617,091 units of the pharmaceutical product Tenofovir Disop Fum 300 mg Tablets. This order has a completion date of May 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Tenofovir Disoproxil Fumarate 300 mg tablets. The contract has a ceiling value of $4,182.87 and a completion date of July 18, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,422.80 firm fixed-price delivery order is for the supply of Tenofovir Disoproxil Fumarate 300 mg tablets. The contract has an ultimate completion date of March 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $2,374.83 firm fixed price delivery order is for the supply of 4,564,136 units of Tenofovir Disoproxil Fumarate 300 mg tablets. The award has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $9,625.87 for the supply of Emtricitabine-Tenofovir 200-300mg tablets. The contract has a firm fixed price and an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,811.22 Firm Fixed Price Delivery Order is for the supply of Tenofovir Disoproxil Fumarate 300 mg tablets. This contract is not set aside for any small business designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is a Delivery Order valued at $1,319.35 for the procurement of Tenofovir Disoproxil Fumarate 300 mg tablets. The award does not have a set-aside designation. AmerisourceBergen Drug Corporation is a major pharmaceutical distribution company that holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Tenofovir Disoproxil Fumarate 300 mg tablets in 30-count units, with a ceiling value of $5,720.35 and a completion date of January 9, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Tenofovir Disoproxil Fumarate 300 mg tablets to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) with a ceiling value of $2,374.83 was issued to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has a firm-fixed price pricing structure and an ultimate completion date of July 16, 2024. This IDC serves as the primary vehicle for Amerisourcebergen to...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC3GH
    Delivery Order

This federal contract award, valued at $7,044.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB20D7066|SPE2DB25FC3GH) for the supply of 4,568,192,545 units of Tenofovir Disoproxil Fumarate 300 mg tablets. The contract has a firm fixed price and is set to expire on May 12, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 (SPE2DX), which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard. The current delivery order is not designated as a set-aside contract.

Generated 8/8/25, 10:08 AM